Shorter term studies in AML patients who recently underwent induction chemotherapy have shown that CH clones, often related to the leukemia clone, frequently persist during hematologic remission and are associated with higher incidence of relapse and shorter overall survival.16, 17. Here, C4B is linked to acute myeloid leukemia.